120 related articles for article (PubMed ID: 20236205)
1. Psoriasis: an epidemiological evaluation of disease burden in 590 patients.
Meyer N; Paul C; Feneron D; Bardoulat I; Thiriet C; Camara C; Sid-Mohand D; Le Pen C; Ortonne JP
J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1075-82. PubMed ID: 20236205
[TBL] [Abstract][Full Text] [Related]
2. Nail psoriasis in Germany: epidemiology and burden of disease.
Augustin M; Reich K; Blome C; Schäfer I; Laass A; Radtke MA
Br J Dermatol; 2010 Sep; 163(3):580-5. PubMed ID: 20456340
[TBL] [Abstract][Full Text] [Related]
3. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.
Augustin M; Krüger K; Radtke MA; Schwippl I; Reich K
Dermatology; 2008; 216(4):366-72. PubMed ID: 18319601
[TBL] [Abstract][Full Text] [Related]
4. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis among Sarawakian natives in a tertiary skin centre in Sarawak.
Yap FB
Australas J Dermatol; 2010 Aug; 51(3):210-1. PubMed ID: 20695864
[TBL] [Abstract][Full Text] [Related]
6. Role of depression in quality of life for patients with psoriasis.
Schmitt JM; Ford DE
Dermatology; 2007; 215(1):17-27. PubMed ID: 17587835
[TBL] [Abstract][Full Text] [Related]
7. What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region.
García-Diez A; Foraster CF; Sebastián FV; Tudela LL; Llach XB; Fernández GS
Dermatology; 2008; 216(2):137-51. PubMed ID: 18216476
[TBL] [Abstract][Full Text] [Related]
8. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
[TBL] [Abstract][Full Text] [Related]
9. Suffering in psoriasis patients: its relation with illness severity and subjective well-being.
Reimus JL; Vingerhoets AJ; Soons PH; Korstanje MJ
Int J Dermatol; 2007 Oct; 46(10):1042-5. PubMed ID: 17910711
[TBL] [Abstract][Full Text] [Related]
10. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach.
Schmitt J; Ford DE
Gen Hosp Psychiatry; 2007; 29(2):134-40. PubMed ID: 17336662
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores.
de Jager ME; van de Kerkhof PC; de Jong EM; Seyger MM
Br J Dermatol; 2010 Nov; 163(5):1099-101. PubMed ID: 20716218
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
Reich K; Krüger K; Mössner R; Augustin M
Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
[TBL] [Abstract][Full Text] [Related]
13. Changes in mood predict disease activity and quality of life in patients with psoriasis following emotional disclosure.
Vedhara K; Morris RM; Booth R; Horgan M; Lawrence M; Birchall N
J Psychosom Res; 2007 Jun; 62(6):611-9. PubMed ID: 17540218
[TBL] [Abstract][Full Text] [Related]
14. The relationship between symptoms and patient characteristics among psoriasis patients.
Bilac C; Ermertcan AT; Bilac DB; Deveci A; Horasan GD
Indian J Dermatol Venereol Leprol; 2009; 75(5):551. PubMed ID: 19736461
[TBL] [Abstract][Full Text] [Related]
15. How patients experience psoriasis: results from a European survey.
Fouéré S; Adjadj L; Pawin H
J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():2-6. PubMed ID: 16274404
[TBL] [Abstract][Full Text] [Related]
16. Quality of psoriasis care in Germany--results of the national study PsoHealth 2007.
Augustin M; Reich K; Reich C; Purwins S; Jeff Rustenbach S; Schäfer I; Radtke M
J Dtsch Dermatol Ges; 2008 Aug; 6(8):640-5. PubMed ID: 18801145
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study.
Jacobi A; Kupke C; Behzad M; Hertl M
Int J Dermatol; 2013 Sep; 52(9):1081-7. PubMed ID: 23432542
[TBL] [Abstract][Full Text] [Related]
18. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
[TBL] [Abstract][Full Text] [Related]
19. Time needed for treatment is the major predictor of quality of life in psoriasis.
Blome C; Simianer S; Purwins S; Laass A; Rustenbach SJ; Schaefer I; Radtke M; Augustin M
Dermatology; 2010; 221(2):154-9. PubMed ID: 20558972
[TBL] [Abstract][Full Text] [Related]
20. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
